Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 10:41 am Sale |
2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
Foresite Capital Fund III L.P. | 3,428,898 5.000% |
-390,828 (-10.23%) |
Filing History |
| 2021-02-10 10:46 am Sale |
2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
The Vanguard Group | 3,427,011 4.970% |
-264,314 (-7.16%) |
Filing History |
| 2021-01-29 09:57 am Sale |
2020-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
BLACKROCK INC BLK |
5,386,244 7.800% |
-203,607 (-3.64%) |
Filing History |
| 2020-09-24 4:47 pm Purchase |
2020-09-14 | 13G | CymaBay Therapeutics, Inc. CBAY |
Boxer Capital LLC | 4,000,000 5.800% |
4,000,000 (New Position) |
Filing History |
| 2020-09-01 12:25 pm Purchase |
2020-08-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
AVORO CAPITAL ADVISORS LLC | 10,300,000 14.950% |
4,800,000 (+87.27%) |
Filing History |
| 2020-06-05 4:02 pm Purchase |
2020-05-26 | 13G | CymaBay Therapeutics, Inc. CBAY |
SHAW D E & CO L P | 3,449,612 5.000% |
3,449,612 (New Position) |
Filing History |
| 2020-05-13 09:00 am Sale |
2020-05-12 | 13D | CymaBay Therapeutics, Inc. CBAY |
Engine Capital, L.P. | 2,097,676 3.000% |
-4,346,301 (-67.45%) |
Filing History |